Journal ArticleJ Thorac Oncol · October 2025
In the past 50 years, we have seen a dramatic evolution in thoracic oncology. We have gone from a time of limited understanding of the biology of lung cancer, no demonstrated benefits for screening, and marginal benefits from therapy to an era of molecular ...
Full textLink to itemCite
ConferenceThe Journal of thoracic and cardiovascular surgery · September 2025
BackgroundFive-year disease recurrence rates for patients with stage I non-small cell lung cancer (NSCLC) postsurgery are variable (15%-40%). There is an urgent need for novel biomarker strategies to identify high-risk patients who may benefit fro ...
Full textCite
Journal ArticleJ Thorac Cardiovasc Surg · May 2025
OBJECTIVE: Clinical trials play a critical role in the rapidly evolving field of cardiothoracic surgery and the American Association for Thoracic Surgery Clinical Trials Methods Course has provided a biannual symposium led by preeminent surgeons with vast ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 2025
OBJECTIVE: Presentation with multiple ground-glass opacities (GGOs) is an increasingly common occurrence, and the optimal management of these lesions is unclear. Active surveillance has been increasingly adopted as a management strategy for other low-grade ...
Full textLink to itemCite
Journal ArticlePract Radiat Oncol · 2025
PURPOSE: The phase 3 Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy study implemented centralized quality assurance (QA) to mitigate risks of protocol deviations. This report summarizes the quality and compliance of the first 100 partici ...
Full textLink to itemCite
Journal ArticleAnesth Analg · January 1, 2025
BACKGROUND: Obstructive sleep apnea is associated with increased dementia risk, yet its role in postoperative neurocognitive disorders is unclear. Here, we studied whether the severity of untreated obstructive sleep apnea is associated with the severity of ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · October 2024
Advances in the multidisciplinary care of early stage resectable NSCLC (rNSCLC) are emerging at an unprecedented pace. Numerous phase 3 trials produced results that have transformed patient outcomes for the better, yet these findings also require important ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · July 2024
BACKGROUND: Despite surgical resection, long-term survival of patients with resectable non-small cell lung cancer (NSCLC) remains poor. Adjuvant chemotherapy, the standard of care for locally advanced NSCLC, provides a marginal 5.4% benefit in survival. Im ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · January 2024
Outcomes for patients with esophageal cancer have improved over the last decade with the implementation of multimodality therapy. There are currently no comprehensive guidelines addressing multidisciplinary management of esophageal cancer that have incorpo ...
Full textLink to itemCite
Journal ArticlePract Radiat Oncol · 2024
Outcomes for patients with esophageal cancer have improved over the last decade with the implementation of multimodality therapy. There are currently no comprehensive guidelines addressing multidisciplinary management of esophageal cancer that have incorpo ...
Full textLink to itemCite
Journal ArticleAnn Surg · December 1, 2023
OBJECTIVES: To characterize and quantify accumulating immunologic alterations, pre and postoperatively in patients undergoing elective surgical procedures. BACKGROUND: Elective surgery is an anticipatable, controlled human injury. Although the human respon ...
Full textLink to itemCite
Journal ArticleChest Pulmonary · December 1, 2023
Background: Standard-of-care treatment options for stage I non-small cell lung cancer (NSCLC) include surgery and stereotactic body radiation therapy (SBRT). Notwithstanding a lack of prospective evidence demonstrating superior long-term survival with eith ...
Full textCite
Journal ArticleN Engl J Med · November 2, 2023
BACKGROUND: Neoadjuvant or adjuvant immunotherapy can improve outcomes in patients with resectable non-small-cell lung cancer (NSCLC). Perioperative regimens may combine benefits of both to improve long-term outcomes. METHODS: We randomly assigned patients ...
Full textLink to itemCite
Journal ArticleJto Clinical and Research Reports · October 1, 2023
Introduction: Postoperative radiotherapy (PORT) reduces local failure in patients with NSCLC, without a clear overall survival benefit. It is unknown whether the subsets of patients benefit. Two recent large randomized controlled trials, PORT-C (People's R ...
Full textCite
Journal ArticleAnn Surg · July 1, 2023
OBJECTIVE: To determine the threshold annualized esophagectomy volume that is associated with improved survival, oncologic resection, and postoperative outcomes. BACKGROUND: Esophagectomy at high-volume centers is associated with improved outcomes; however ...
Full textLink to itemCite
Journal ArticleAnn Surg · March 1, 2023
BACKGROUND: The outcomes associated with receipt of adjuvant radiation in patients after surgery for MPM are poorly understood. OBJECTIVE: The objective of this study was to use 2 registries to compare the outcomes of patients receiving adjuvant radiation ...
Full textLink to itemCite
Journal ArticleLung Cancer · January 2023
INTRODUCTION: Patients receiving stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) are typically inoperable, in concordance with guidelines that advocate surgical resection as preferred treatment for operable patients ...
Full textLink to itemCite
Journal ArticleAnn Surg · December 1, 2022
BACKGROUND: Although SABR is increasingly emerging as an alternative to surgery for node-negative non-small cell lung cancer, there is poor understanding of patients who may most benefit SABR compared to surgery. OBJECTIVE: This study examined the relation ...
Full textLink to itemCite
Journal ArticleAnn Surg · June 1, 2022
OBJECTIVE: To design and establish a prospective biospecimen repository that integrates multi-omics assays with clinical data to study mechanisms of controlled injury and healing. BACKGROUND: Elective surgery is an opportunity to understand both the system ...
Full textLink to itemCite
Journal ArticleClin Lung Cancer · May 2022
For patients with resectable, early-stage non-small-cell lung cancer (NSCLC), surgery is the primary treatment; however, 5-year survival rates remain poor. Postoperative adjuvant platinum-doublet chemotherapy is associated with a statistically significant ...
Full textLink to itemCite
Journal ArticleAnn Surg · March 1, 2022
BACKGROUND: We hypothesized that the ratio of positive lymph nodes to total assessed lymph nodes (LNR) is an indicator of cancer burden in esophageal adenocarcinoma and may identify patients who may most benefit from AC. OBJECTIVE: The aim of this study wa ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2022
BACKGROUND: Endoscopic resection (ER) is the preferred treatment for superficial esophageal cancer; however, a safe time frame for performing ER has not been established. This study evaluated the period in which ER can be performed for patients with stage ...
Full textLink to itemCite
Journal ArticleAnn Surg · February 1, 2022
OBJECTIVE: Determine whether adjuvant chemotherapy is associated with a survival benefit in high risk T2-4a, pathologically node-negative distal esophageal adenocarcinoma. SUMMARY OF BACKGROUND DATA: There is minimal literature to substantiate the NCCN gui ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · February 2022
OBJECTIVES: Pembrolizumab is a programmed death receptor-1 masking antibody approved for metastatic non-small cell lung cancer. This Phase 2 study (NCT02818920) of neoadjuvant pembrolizumab in non-small cell lung cancer had a primary end point of safety an ...
Full textLink to itemCite
Journal ArticleAnn Clin Transl Neurol · February 2022
OBJECTIVE: Numerous investigators have theorized that postoperative changes in Alzheimer's disease neuropathology may underlie postoperative neurocognitive disorders. Thus, we determined the relationship between postoperative changes in cognition and cereb ...
Full textOpen AccessLink to itemCite
Journal ArticleBr J Anaesth · December 2021
BACKGROUND: Cognitive dysfunction after surgery is a major issue in older adults. Here, we determined the effect of APOE4 on perioperative neurocognitive function in older patients. METHODS: We enrolled 140 English-speaking patients ≥60 yr old scheduled fo ...
Full textOpen AccessLink to itemCite
Journal ArticleSurgery · June 2021
BACKGROUND: There are conflicting reports in the literature comparing outcomes after open Ravitch and minimally invasive Nuss procedures for pectus excavatum repair, and there is relatively little data available comparing the outcomes of these procedures p ...
Full textLink to itemCite
ConferenceJ Thorac Cardiovasc Surg · April 2021
BACKGROUND: There is poor understanding of the comparative effectiveness of lobar and sublobar resections for limited-stage small cell lung cancer (SCLC). We analyzed the National Cancer Database to examine the outcomes of patients undergoing wedge resecti ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2021
BACKGROUND: Older patients are often considered high-risk surgical candidates for locally advanced esophageal cancer, and the benefit of surgery in this population is unclear. This national analysis examines the effect of age on esophagectomy outcomes and ...
Full textLink to itemCite
Journal ArticleSci Rep · February 4, 2021
Arachidonic acid (AA), docosahexaenoic acid (DHA), and eicosapentaenoic acid (EPA) derived lipids play key roles in initiating and resolving inflammation. Neuro-inflammation is thought to play a causal role in perioperative neurocognitive disorders, yet th ...
Full textOpen AccessLink to itemCite
Journal ArticleAnn Thorac Surg · February 2021
BACKGROUND: Induction therapy for patients with cT2N0M0 esophageal cancer is controversial. We performed a retrospective cohort analysis of the National Cancer Database to examine the patterns of use of induction therapy for this population. METHODS: The N ...
Full textLink to itemCite
Journal ArticleChest · January 2021
BACKGROUND: The interaction between tumor size and the comparative prognosis of lobar and sublobar resection has been defined poorly. RESEARCH QUESTION: The purpose of this study was to characterize the relationship between tumor size and the receipt of se ...
Full textLink to itemCite
Journal ArticleJ Alzheimers Dis · 2021
BACKGROUND: Postoperative cognitive dysfunction (POCD), a syndrome of cognitive deficits occurring 1-12 months after surgery primarily in older patients, is associated with poor postoperative outcomes. POCD is hypothesized to result from neuroinflammation; ...
Full textOpen AccessLink to itemCite
Journal ArticleThe Annals of thoracic surgery · December 2020
BackgroundThe National Comprehensive Cancer Network guidelines recommend surgery for limited stage small cell lung cancer (SCLC). However, there is no literature on minimum acceptable lymph node retrieval in surgery for SCLC.MethodsThe Na ...
Full textCite
Journal ArticleAnn Thorac Surg · December 2020
BACKGROUND: The aims of this study were to examine the factors associated with use of neoadjuvant chemoradiotherapy (NCR) for patients with locally advanced esophageal cancer and to evaluate the effect of NCR on survival. METHODS: The 2004 to 2015 National ...
Full textLink to itemCite
Journal ArticleJ Natl Cancer Inst · November 1, 2020
BACKGROUND: There is no standard of care with respect to the use of neoadjuvant chemotherapy (NAC) in resectable malignant pleural mesothelioma (MPM). We performed an intention-to-treat analysis with data from a single institution and the National Cancer D ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · November 2020
INTRODUCTION: Surgical resection is curative for some patients with early lung squamous cell carcinoma. Staging and clinical factors do not adequately predict recurrence risk. We sought to validate the discriminative performance of proposed prognostic gene ...
Full textLink to itemCite
Journal ArticleCurr Hypertens Rep · October 23, 2020
PURPOSE OF REVIEW: To highlight the indications, procedural considerations, and data supporting the use of stellate ganglion blockade (SGB) for management of refractory ventricular arrhythmias. RECENT FINDINGS: In patients with refractory ventricular arrhy ...
Full textOpen AccessLink to itemCite
Journal ArticleAnn Thorac Surg · September 2020
BACKGROUND: Adjuvant chemotherapy (AC) after esophagectomy improves survival in esophageal cancer when induction therapy is not given; however, the optimal timing for initiation of AC is poorly characterized. We aimed to determine the impact of timing of A ...
Full textLink to itemCite
ConferenceJ Thorac Cardiovasc Surg · July 2020
OBJECTIVES: To examine guideline concordance across a national sample and determine the relationship between socioeconomic factors, use of recommended postoperative adjuvant therapy, and outcomes for patients with resected pN1 or pN2 non-small cell lung ca ...
Full textLink to itemCite
ConferenceJ Thorac Cardiovasc Surg · July 2020
BACKGROUND: Endoscopic resection has emerged as a treatment option for T1a esophageal cancer, but the impact of age on patient selection for surgery versus endoscopic resection has not been well studied. We hypothesized that endoscopic resection would be a ...
Full textLink to itemCite
Journal ArticleJ Neurol · July 2020
OBJECTIVE: Lumbar punctures (LPs) are important for obtaining CSF in neurology studies but are associated with adverse events and feared by many patients. We determined adverse event rates and pain scores in patients prospectively enrolled in two cohort st ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · May 2020
BACKGROUND: The significance of indeterminate margins following surgery for non-small cell lung cancer (NSCLC) is unknown. We evaluated the influence of adjuvant therapy on survival in patients whose cancer showed indeterminate margins. METHODS: Patients w ...
Full textLink to itemCite
Journal ArticleJ Surg Res · May 2020
BACKGROUND: We performed a nationwide analysis to assess the impact of adjuvant therapy on survival after a microscopically margin-positive (R1) resection for esophageal cancer. METHODS: The National Cancer Database was used to identify patients with R1 re ...
Full textLink to itemCite
Journal ArticleJACC Clin Electrophysiol · May 2020
OBJECTIVES: This study sought to describe our institutional experience with establishing a neurocardiology service in an attempt to provide autonomic modulation as a treatment for ventricular arrhythmias (VAs). BACKGROUND: Treatment-refractory VAs are comm ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 2020
BACKGROUND: There are limited data on the safe interval from diagnosis to surgery in patients with stage I esophageal adenocarcinoma. We hypothesized that increased time to surgery would be associated with worse survival and increased nodal upstaging. METH ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · December 2019
BACKGROUND: The National Comprehensive Cancer Network guidelines recommend consideration of surgery for clinical T4a esophageal adenocarcinoma. There are limited data on the outcomes of patients with T4a adenocarcinoma treated with surgery vs definitive ch ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · December 2019
INTRODUCTION: There are limited small, single-institution observational studies examining the role of surgery in large cell neuroendocrine cancer (LCNEC). We investigated the outcomes of surgery for stage I to IIIA LCNEC by using the National Cancer Databa ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · December 2019
BACKGROUND: Because surgery is rarely recommended, there is minimal literature comparing the outcomes of surgery and chemoradiation in stage N3 non-small cell lung cancer (NSCLC). We examined the outcomes of definitive chemoradiation versus multimodality t ...
Full textLink to itemCite
Journal ArticleAnesth Analg · November 2019
Animal models suggest postoperative cognitive dysfunction may be caused by brain monocyte influx. To study this in humans, we developed a flow cytometry panel to profile cerebrospinal fluid (CSF) samples collected before and after major noncardiac surgery ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Thorac Oncol · October 2019
The accurate diagnosis of mesothelioma is critical for the appropriate clinical management of this cancer. Many issues complicate making the diagnosis of mesothelioma including the presence of reactive mesothelial cells in benign pleural effusions, the het ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · October 2019
Detailed guidelines pertaining to radiological assessment of malignant pleural mesothelioma are currently lacking due to the rarity of the disease, complex morphology, propensity to invade multiple planes simultaneously, and lack of specific recommendation ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2019
BACKGROUND: Current guidelines do not routinely recommend adjuvant therapy for resected stage I large cell lung neuroendocrine cancer (LCNEC). However, data regarding the role of adjuvant therapy in early LCNEC are limited. This National Cancer Database (N ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · August 2019
This article is a joint effort arising from a task force formed at a National Cancer Institute-International Association for the Study of Lung Cancer-Mesothelioma Applied Research Foundation Mesothelioma Clinical Trials Planning Meeting, held at the NIH in ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · July 2019
INTRODUCTION: Detailed guidelines regarding the use of radiation therapy for malignant pleural mesothelioma (MPM) are currently lacking because of the rarity of the disease, the wide spectrum of clinical presentations, and the paucity of high-level data on ...
Full textLink to itemCite
Journal ArticleAnesthesiology · June 2019
BACKGROUND: Cognitive decline after cardiac surgery occurs frequently and persists in a significant proportion of patients. Preclinical studies and human trials suggest that intravenous lidocaine may confer protection in the setting of neurologic injury. I ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Am Geriatr Soc · April 2019
BACKGROUND/OBJECTIVES: Every year, up to 40% of the more than 16 million older Americans who undergo anesthesia/surgery develop postoperative cognitive dysfunction (POCD) or delirium. Each of these distinct syndromes is associated with decreased quality of ...
Full textOpen AccessLink to itemCite
Journal ArticleAnn Surg · January 2019
OBJECTIVE: The objective of this study was to compare the long-term survival of open versus thoracoscopic (VATS) lobectomy for early stage non-small-cell lung cancer (NSCLC). BACKGROUND: Data from national studies on long-term survival for VATS versus open ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · January 2019
OBJECTIVES: Anti-programmed cell death 1 (PD-1)/programmed death ligand 1 (PD-L1) immunotherapy has demonstrated success in the treatment of advanced NSCLC. Recently, PD-1/PD-L1 blockade also has demonstrated interesting results in small trials of neoadjuv ...
Full textLink to itemCite
Journal ArticleAnn Surg · December 2018
OBJECTIVE: To determine whether surgery with adjuvant chemotherapy offers a survival advantage over concurrent chemoradiation for patients with cT1-2N0M0 small cell lung cancer (SCLC). BACKGROUND: Although surgery with adjuvant chemotherapy is the recommen ...
Full textLink to itemCite
Journal ArticleLaryngoscope · December 2018
OBJECTIVES/HYPOTHESIS: Vocal fold paralysis/paresis (VFP) is an uncommon but serious complication following esophagectomy. The objectives of this study were to: 1) identify the prevalence of VFP and associated complications after esophagectomy in the Unite ...
Full textOpen AccessLink to itemCite
Journal ArticleJ Thorac Oncol · November 2018
On March 28- 29, 2017, the National Cancer Institute (NCI) Thoracic Malignacy Steering Committee, International Association for the Study of Lung Cancer, and Mesothelioma Applied Research Foundation convened the NCI-International Association for the Study ...
Full textLink to itemCite
Journal ArticleBMJ Support Palliat Care · September 2018
OBJECTIVES: Patients receiving induction chemotherapy for acute myeloid leukaemia (AML) anecdotally describe poor sleep, but sleep disturbances have not been well-characterised in this population. We aimed to test the feasibility of measuring sleep quality ...
Full textLink to itemCite
Journal ArticleEcol Lett · September 2018
Environmental change can result in substantial shifts in community composition. The associated immigration and extinction events are likely constrained by the spatial distribution of species. Still, studies on environmental change typically quantify biotic ...
Full textLink to itemCite
ConferenceInternational Archives of the Photogrammetry Remote Sensing and Spatial Information Sciences ISPRS Archives · May 30, 2018
Grassland ecology experiments in remote locations requiring quantitative analysis of the biomass in defined plots are becoming increasingly widespread, but are still limited by manual sampling methodologies. To provide a cost-effective automated solution f ...
Full textCite
Journal ArticlePlant and Soil · April 1, 2018
Background and aims: Arbuscular mycorrhizal fungi (AMF) are important for plant nutrient and water acquisition. Much is known about how nutrient addition and environment affect AMF, but little is known about nutrient by environment interactions. We measure ...
Full textCite
Journal ArticleEcology · April 2018
Plant stoichiometry, the relative concentration of elements, is a key regulator of ecosystem functioning and is also being altered by human activities. In this paper we sought to understand the global drivers of plant stoichiometry and compare the relative ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2018
BACKGROUND: The objective of this study was to evaluate the safety and feasibility of using neoadjuvant chemotherapy plus ipilimumab followed by surgery as a treatment strategy for stage II-IIIA non-small cell lung cancer. METHODS: From 2013 to 2017, posto ...
Full textLink to itemCite
Journal ArticleJournal of Ecology. · January 2018
Reductions in community evenness can lead to local extinctions as dominant species exclude subordinate species; however, herbivores can prevent competitive exclusion by consuming otherwise dominant plant species, thus increasing evenness. While these predi ...
Full textCite
Journal ArticleNat Ecol Evol · January 2018
Biodiversity is declining in many local communities while also becoming increasingly homogenized across space. Experiments show that local plant species loss reduces ecosystem functioning and services, but the role of spatial homogenization of community co ...
Full textLink to itemCite
Journal ArticleJournal of Applied Ecology. · January 2018
Global concern about human impact on biological diversity has triggered an intense research agenda on drivers and consequences of biodiversity change in parallel with international policy seeking to conserve biodiversity and associated ecosystem functions. ...
Full textCite
Journal ArticleClin Cancer Res · December 15, 2017
Purpose: To determine the immunologic effects of neoadjuvant chemotherapy plus ipilimumab in early-stage non-small cell lung cancer (NSCLC) patients.Experimental Design: This is a single-arm chemotherapy plus phased ipilimumab phase II study of 24 treatmen ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · December 2017
INTRODUCTION: The combined impact of advances in diagnosis and treatment of stage I NSCLC has not been assessed comprehensively. To define the survival impact of modern staging and treatment techniques for clinical stage I NSCLC, the Veterans Administratio ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2017
BACKGROUND: Although the use of adjuvant chemotherapy in patients with pathologically node-positive (pN+) atypical carcinoid tumor of the lung is an accepted practice, controversy exists about its use in pathologically node-negative (pN0) patients. Our aim ...
Full textLink to itemCite
Journal ArticleFunctional Ecology. · September 2017
The paradigmatic hypothesis for the effect of fertilisation on plant diversity represents a one‐dimensional trade‐off for plants competing for below‐ground nutrients (generically) and above‐ground light: fertilisation reduces competition for nutrients whil ...
Full textCite
Journal ArticleJ Natl Cancer Inst · August 1, 2017
BACKGROUND: : Propensity score (PS) analysis is increasingly being used in observational studies, especially in some cancer studies where random assignment is not feasible. This systematic review evaluates the use and reporting quality of PS analysis in on ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · August 2017
OBJECTIVE: Lobectomy is considered optimal therapy for early-stage non-small cell lung cancer, but sublobar wedge resection and stereotactic body radiation therapy are alternative treatments. This study compared outcomes between wedge resection and stereot ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · June 2017
BACKGROUND: Adjuvant chemotherapy has been demonstrated to improve the outcomes of patients with N1 non-small cell lung cancer. It is unknown whether patients previously thought to have unresectable small cell lung cancer (SCLC) may have tumors amenable to ...
Full textLink to itemCite
Journal ArticleNat Ecol Evol · April 20, 2017
Earth's biodiversity and carbon uptake by plants, or primary productivity, are intricately interlinked, underlie many essential ecosystem processes, and depend on the interplay among environmental factors, many of which are being changed by human activitie ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · April 2017
BACKGROUND: This study examined the association of extent of lung resection, pathologic nodal evaluation, and survival for patients with clinical stage I (cT1-2N0M0) adenocarcinoma with lepidic histologic features in the National Cancer Data Base. METHODS: ...
Full textLink to itemCite
Journal ArticleClin Lung Cancer · January 2017
BACKGROUND: Patients with limited metastases, oligometastases (OMs), might have improved outcomes compared with patients with widespread distant metastases (DMs). The incidence and behavior of OMs from non-small-cell lung cancer (NSCLC) need further charac ...
Full textLink to itemCite
Journal ArticleFront Syst Neurosci · 2017
Each year over 16 million older Americans undergo general anesthesia for surgery, and up to 40% develop postoperative delirium and/or cognitive dysfunction (POCD). Delirium and POCD are each associated with decreased quality of life, early retirement, incr ...
Full textOpen AccessLink to itemCite
Journal ArticleAnn Thorac Surg · December 2016
BACKGROUND: The long-term survival benefit of lobectomy over sublobar resection for early-stage non-small cell lung cancer must be weighed against a potentially increased risk of perioperative mortality. The objective of the current study was to create a r ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2016
BACKGROUND: This study analyzes the impact of age on perioperative outcomes and long-term survival of patients undergoing surgery after induction chemotherapy for non-small cell lung cancer. METHODS: Short- and long-term outcomes of patients with non-small ...
Full textLink to itemCite
Journal ArticleClin Lung Cancer · September 2016
BACKGROUND: Although malignant pleural mesothelioma (MPM) is generally a disease associated with more advanced age, the association of age, treatment, and outcomes has not been well-characterized. We evaluated the impact of age on outcomes in patients with ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2016
BACKGROUND: Guidelines recommend primary surgical resection for non-small cell lung cancer (NSCLC) patients with clinical N1 disease and adjuvant chemotherapy if nodal disease is confirmed after resection. We tested the hypothesis that induction chemothera ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2016
BACKGROUND: The objective of this study was to evaluate outcomes of minimally invasive approaches to esophagectomy using population-level data. METHODS: Multivariable regression modeling was used to determine predictors associated with the use of minimally ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · June 2016
OBJECTIVES: Video-assisted thoracoscopic (VATS) lobectomy is increasingly accepted for the management of early-stage non-small cell lung cancer (NSCLC), but its role for locally advanced cancers has not been as well characterized. We compared outcomes of p ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · June 2016
OBJECTIVES: We evaluated the impact of patient selection and treatment strategies on long-term outcomes of patients who had lobectomy after induction therapy for stage IIIA pN2 non-small cell lung cancer (NSCLC). METHODS: The impact of various patient sele ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · April 1, 2016
PURPOSE: Data on optimal adjuvant therapy after complete resection of small-cell lung cancer (SCLC) are limited, and in particular, there have been no studies evaluating the role of adjuvant chemotherapy, with or without prophylactic cranial irradiation, r ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2016
BACKGROUND: Previous studies have raised concerns that video-assisted thoracoscopic (VATS) lobectomy may compromise nodal evaluation. The advantages or limitations of robotic lobectomy have not been thoroughly evaluated. METHODS: Perioperative outcomes and ...
Full textLink to itemCite
Journal ArticleThorac Surg Clin · February 2016
The process of metastasis relies on a series of stochastic and sequential steps, with selective pressure exerted on a large number of genetically volatile cancer cells to produce a very small fraction of tumor cells with the ability to navigate the transit ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · December 2015
OBJECTIVE: Radiotherapy is commonly used in induction regimens for patients with non-small cell lung cancer with operable mediastinal nodal disease, although evidence has not shown a benefit over induction chemotherapy alone. We compared outcomes between i ...
Full textLink to itemCite
Journal ArticleSci Transl Med · August 26, 2015
The high-grade pulmonary neuroendocrine tumors, small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC), remain among the most deadly malignancies. Therapies that effectively target and kill tumor-initiating cells (TICs) in these canc ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · July 2015
BACKGROUND: Pulmonary function tests predict respiratory complications after lobectomy. We evaluated the impact of pulmonary function measurements on long-term survival after lobectomy for stage I non-small cell lung cancer. METHODS: The relationship betwe ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · June 2015
BACKGROUND: Salvage surgical resection for non-small cell lung cancer (NSCLC) patients initially treated with definitive chemotherapy and radiotherapy can be performed safely, but the long-term benefits are not well characterized. METHODS: Perioperative co ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · October 2014
On February 2, 2012, the National Cancer Institute (NCI) sponsored a 2-day workshop with the NCI Thoracic Malignancies Steering Committee and the Food and Drug Administration to bring together leading academicians, clinicians, industry and government repre ...
Full textLink to itemCite
ConferenceCancer Research · October 1, 2014
AbstractThe ALK gene fusion results in the constitutive activation of the oncogenic ALK kinase activity through the expression of 3`ALK gene downstream of fusion partners like EML4 and KIF5B. Due to this rea ...
Full textCite
Journal ArticleJ Thorac Cardiovasc Surg · July 2013
OBJECTIVE: Accurate pathologic restaging of N2 stations after neoadjuvant therapy in stage IIIA (N2) non-small cell lung cancer is needed. METHODS: A prospective multi-institutional trial was designed to judge the feasibility of videothoracoscopy to restag ...
Full textLink to itemCite
ConferenceCancer Research · April 15, 2013
AbstractBackground: Fluoro-deoxyglucose positron emission tomography (FDG-PET) scans are used for diagnosis and staging of known or suspected non-small cell lung cancer (NSCLC). Single institution studies ex ...
Full textCite
Journal ArticleCancer · October 15, 2012
BACKGROUND: Studies examining the impact of lower socioeconomic status (SES) on the outcomes of patients with nonsmall cell lung cancer (NSCLC) are inconsistent. The objective of this study was to clearly elucidate the association between SES, education, a ...
Full textLink to itemCite
Journal ArticleAnn Surg · September 2012
OBJECTIVE: Using a national database, we asked whether video-assisted thoracoscopic surgery (VATS) lobectomy is beneficial in high-risk pulmonary patients. BACKGROUND: Single-institution series demonstrated benefit of VATS lobectomy over lobectomy via thor ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · May 1, 2012
PURPOSE: To assess the impact of increasing experience with intensity-modulated radiation therapy (IMRT) after extrapleural pneumonectomy (EPP) for malignant pleural mesothelioma (MPM). METHODS AND MATERIALS: The records of all patients who received IMRT f ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2012
BACKGROUND: Distinguishing between synchronous primary lung cancers and metastatic disease in patients with bilateral lung masses is often difficult. The objective of this study is to examine outcomes associated with a strategy of performing staged bilater ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · April 2012
OBJECTIVES: Lobectomy with an en-bloc chest wall resection is an effective but potentially morbid treatment of lung cancer invading the chest wall. Minimally invasive approaches to lobectomy have reduced morbidity compared with thoracotomy for early stage ...
Full textLink to itemCite
Journal ArticleSurg Oncol Clin N Am · January 2012
Lung cancer is the most common malignancy in the United States and worldwide. In 2011, it is estimated that more than 221,000 people in the United States will be diagnosed with cancer of the lung and bronchus. For patients with early-stage disease, 5-year ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · December 2011
BACKGROUND: Management of patients requiring antiplatelet therapy with clopidogrel (Plavix) and major lung resection must balance the risks of bleeding and cardiovascular events. We reviewed our experience with patients treated with clopidogrel perioperati ...
Full textLink to itemCite
Journal ArticleJ Anesth · October 2011
PURPOSE: We hypothesized that patients who received ketamine during thoracic surgery would benefit from suppression of the inflammatory cascade, represented by lower interleukin (IL)-6 and C-reactive protein (CRP) plasma levels. METHODS: This study was a r ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · June 2011
OBJECTIVE: Age is an important risk factor for morbidity after lung resection. This study was performed to identify specific risk factors for complications after lung resection in octogenarians. METHODS: A prospective database containing patients aged 80 y ...
Full textLink to itemCite
Journal ArticleOecologia · May 2011
The niche dimension hypothesis predicts that greater numbers of limiting factors can allow greater numbers of species to coexist through species' tradeoffs for different limiting factors. A prediction that follows is that addition of multiple limiting reso ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2011
BACKGROUND: One aspect of the cancer stem cell hypothesis is that patients with tumors that exhibit stem-like phenotypes have poor prognoses. Distal epithelial progenitors from lungs early in development demonstrate both self-renewal and potential to diffe ...
Full textLink to itemCite
OtherN Engl J Med · March 24, 2011
To the Editor: We would like to retract our article, "A Genomic Strategy to Refine Prognosis in Early-Stage Non-Small-Cell Lung Cancer,"(1) which was published in the Journal on August 10, 2006. Using a sample set from a study by the American College of Su ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · December 2010
OBJECTIVE: This study assesses the effect of using a comprehensive swallowing evaluation before starting oral feedings on aspiration detection and pneumonia occurrence after esophagectomy. METHODS: The records of all patients undergoing esophagectomy betwe ...
Full textLink to itemCite
Journal ArticleDiversity and Distributions · November 1, 2010
Aim Increasingly, ecologists are using evolutionary relationships to infer the mechanisms of community assembly. However, modern communities are being invaded by non-indigenous species. Since natives have been associated with one another through evolutiona ...
Full textCite
Journal ArticleAnn Thorac Surg · August 2010
BACKGROUND: Atrial fibrillation is responsible for significant morbidity after lung cancer surgery, and preoperative and perioperative risk factors are not well described. METHODS: The Society of Thoracic Surgeons (STS) database was queried for all lobecto ...
Full textLink to itemCite
Journal ArticleEur J Cardiothorac Surg · April 2010
OBJECTIVE: Recent evidence suggests that lobectomy performed either through thoracoscopy (TL) or via a posterolateral thoracotomy (PLT) produces equivalent oncologic outcomes in appropriately selected patients. Advantages of thoracoscopic lobectomy include ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2010
BACKGROUND: Pulmonary function tests predict respiratory complications and mortality after lung resection through thoracotomy. We sought to determine the impact of pulmonary function tests upon complications after thoracoscopic lobectomy. METHODS: A model ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · February 2010
BACKGROUND: Several single-institution series have demonstrated that compared with open thoracotomy, video-assisted thoracoscopic lobectomy may be associated with fewer postoperative complications. In the absence of randomized trials, we queried the Societ ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · January 2010
BACKGROUND: Video-assisted thoracoscopic surgical decortication (VATSD) is widely used for treatment of early empyema and hemothorax, but conversion to open thoracotomy for decortication (OD) is more frequent in the setting of complex, chronic empyema. Thi ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2009
BACKGROUND: Studies evaluating risk factors for complications after lobectomy in elderly patients have not adequately analyzed the effect of using minimally invasive approaches. METHODS: A model for morbidity including published preoperative risk factors a ...
Full textLink to itemCite
Journal ArticleChest · October 2009
Over the past 5 to 10 years, we have reached a treatment plateau using standard platinum-based doublets in an unselected population of patients with advanced non-small cell lung cancer (NSCLC). Recent studies have focused on improving patient outcomes with ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · September 2009
Even with the introduction of targeted agents and the establishment of multiple lines of therapy, the median survival for patients with advanced non-small cell lung cancer (NSCLC) does not considerably extend beyond 1 year. Emerging research suggests that ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · August 2009
OBJECTIVES: Advantages of thoracoscopic lobectomy include less postoperative pain, shorter hospitalization, and improved delivery of adjuvant chemotherapy. The incidence of postoperative complications has not been thoroughly assessed. This study analyzes m ...
Full textLink to itemCite
OtherChest · August 2009
BACKGROUND: CT scan measures of emphysema and airway disease have been correlated with lung function in cohorts of subjects with a range of COPD severity. The contribution of CT scan-assessed airway disease to objective measures of lung function and respir ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · June 2009
BACKGROUND: This study was undertaken to review a large series of resections of colorectal pulmonary metastases in the era of modern chemotherapy. METHODS: A retrospective chart review of prospectively maintained thoracic surgery databases identified 378 p ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 20, 2009
11098 Background: There are vast archives of formalin fixed paraffin-embedded (FFPE) tissue samples that are clinically annotated offering great research potential. However, the technology currently available to assess gene expression is limited to fresh, ...
Link to itemCite
Journal ArticleCancer · December 15, 2008
BACKGROUND: A feasibility study examining the effects of supervised aerobic exercise training on cardiopulmonary and quality of life (QOL) endpoints among postsurgical nonsmall cell lung cancer (NSCLC) patients was conducted. METHODS: Using a single-group ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · November 1, 2008
PURPOSE: Adjuvant chemotherapy for resected non-small-cell lung cancer (NSCLC) is now accepted on the basis of several randomized clinical trials (RCTs) that demonstrated improved survival. Although there is strong evidence that adjuvant chemotherapy is ef ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · September 2008
OBJECTIVE: Prospective analyses of quality of life in elderly patients after lobectomy are limited, yet surgeons often recommend suboptimal therapy to these patients on the basis of the belief that lobectomy is poorly tolerated. Surgical decision making in ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · May 20, 2008
7542 Background: Surgery, with or without chemotherapy, is the preferred treatment for early-stage NSCLC. The risk of local/regional recurrence (LRR) after resection is not well defined, but generally considered to be small in comparison to the risk of dis ...
Link to itemCite
Chapter · December 1, 2007
One of the major goals of the International Staging System for Lung Cancer, first introduced in 1986 and subsequently revised in 1997, was the separation of patients into potentially resectable and unresectable categories. This dividing line was set betwee ...
Full textCite
Journal ArticleAnn Thorac Surg · October 2007
BACKGROUND: Previous studies have discouraged limited pulmonary resection for primary lung cancer, but pulmonary segmentectomy has advantages for some patients. Furthermore, while thoracoscopic lobectomy has been increasingly applied with well-demonstrated ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · October 1, 2007
PURPOSE: Standard treatment for advanced non-small-cell lung cancer (NSCLC) includes the use of a platinum-based chemotherapy regimen. However, response rates are highly variable. Newer agents, such as pemetrexed, have shown significant activity as second- ...
Full textLink to itemCite
Journal ArticleThorac Surg Clin · August 2007
Although difficult to precisely define, health care quality is often measured by components of structure, outcomes, and process. One way for thoracic surgeons to evaluate their practices is to compare themselves with evidence-based national guidelines. Out ...
Full textLink to itemCite
Journal ArticleJ Thorac Oncol · July 2007
INTRODUCTION: A stepwise approach to the functional assessment of lung resection candidates is widely accepted, and this approach incorporates the measurement of exercise peak Vo2 when spirometry and radionuclear studies suggest medical inoperability. A ne ...
Full textLink to itemCite
Journal ArticleThorac Surg Clin · May 2007
The goal is to validate a molecular-based tumor model that identifies patients at low-risk for cancer recurrence and who will not benefit from adjuvant chemotherapy. The remaining patients will be randomized to observation (present standard of care) or adj ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · April 2007
BACKGROUND: We conducted a study of patients who underwent anatomic resection with adjuvant chemotherapy to determine if thoracoscopic lobectomy enables more effective administration of adjuvant chemotherapy than lobectomy by thoracotomy. METHODS: We revie ...
Full textLink to itemCite
Journal ArticleInt J Radiat Oncol Biol Phys · March 15, 2007
PURPOSE: Concurrent chemotherapy and radiation therapy (RT) are used to treat patients with esophageal cancer. The optimal combination of chemotherapeutic agents with RT is undefined. We evaluated a combination of capecitabine, carboplatin, and paclitaxel ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · January 2007
OBJECTIVES: The outcomes of patients with metastatic melanoma are poor. Although prognostic models have been developed to predict the occurrence of pulmonary metastasis from cutaneous melanoma, few data exist to define the outcomes of these patients once m ...
Full textLink to itemCite
Journal ArticleCancer · December 15, 2006
BACKGROUND: Early stage lung cancer has a variable prognosis, and there are currently no markers that predict which patients will recur. This study examined the relation between tumor-regulatory T (Treg) cells and total tumor-infiltrating T-cell lymphocyte ...
Full textLink to itemCite
OtherNat Med · November 2006
Using in vitro drug sensitivity data coupled with Affymetrix microarray data, we developed gene expression signatures that predict sensitivity to individual chemotherapeutic drugs. Each signature was validated with response data from an independent set of ...
Full textLink to itemCite
Journal ArticleThorac Surg Clin · November 2006
The results of ACOSOG Z4031 may provide landmark information for the use of proteomic profiling to diagnose lung cancer noninvasively and to provide more accurate predictions of survival. Although the technological developments allowing generalized use of ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2006
BACKGROUND: Mediastinoscopy is a valuable tool for evaluating mediastinal pathology and is essential for establishing treatment strategies in most patients with lung cancer. We sought to determine the complication and false negative rate for mediastinoscop ...
Full textLink to itemCite
Journal ArticleJ Nucl Med · October 2006
UNLABELLED: The American College of Surgeons Oncology Group recently completed a trial evaluating the role of PET with 18F-FDG in patients with documented or suspected non-small cell lung cancer. Subjects underwent standard imaging to exclude metastatic di ...
Link to itemCite
Journal ArticleAnn Surg · September 2006
OBJECTIVE: Advantages of thoracoscopic lobectomy for early stage non-small cell lung cancer (NSCLC), as compared with lobectomy by conventional thoracotomy, include less postoperative pain and shorter length of hospitalization. The outcomes after thoracosc ...
Full textLink to itemCite
Journal ArticleN Engl J Med · August 10, 2006
BACKGROUND: Clinical trials have indicated a benefit of adjuvant chemotherapy for patients with stage IB, II, or IIIA--but not stage IA--non-small-cell lung cancer (NSCLC). This classification scheme is probably an imprecise predictor of the prognosis of a ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · July 2006
BACKGROUND: Thoracoscopic lobectomy is an accepted oncologic approach for early stage non-small cell lung cancer (NSCLC). We conducted a retrospective study of patients who underwent lobectomy after induction therapy to determine the feasibility of thoraco ...
Full textLink to itemCite
Journal ArticleCurr Oncol Rep · July 2006
Despite major developments in targeted biologic agents, patients with advanced non-small-cell lung cancer have a poor prognosis. Recent development of targeted biologic agents have given us insight into possibilities of matching therapy with disease; howev ...
Full textLink to itemCite
Journal ArticleJ Natl Compr Canc Netw · July 2006
Although lung cancer is the leading cause of cancer-related death in the world and has an increased chance of cure if detected at an earlier stage, routine lung cancer screening is currently not recommended in the United States. Unfortunately, most patient ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · June 20, 2006
7026 Background. Although stage-specific classification identifies appropriate populations for adjuvant chemotherapy, this is likely an imprecise predictor for the individual patient with early stage NSCLC. METHODS: Using previously-described methodologies ...
Link to itemCite
Journal ArticleJ Clin Oncol · June 20, 2006
7226 Background: Several molecular targets have been approved for use in patients with non-small cell lung cancer (NSCLC) and several hundred are in various phases of investigation. However, the efficacy of these targets range from 5-15% of the overall pop ...
Link to itemCite
Journal ArticleJ Clin Oncol · June 20, 2006
10059 Background: We previously developed a validated fresh tissue-based genomic risk model in patients with early stage non-small cell lung cancer (NSCLC) using the Affymetrix U133 plus 2.0 Genechip. Limitations of this fresh tissue-based model include th ...
Link to itemCite
Journal ArticleAnn Thorac Surg · June 2006
BACKGROUND: Patients with early stage nonsmall-cell lung cancer who have undergone complete resection have a recurrence rate of approximately 50%, predominately due to the development of systemic metastases. This study is a prospective analysis of the expr ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2006
BACKGROUND: Little prospective, multiinstitutional data exist regarding the morbidity and mortality after major pulmonary resections for lung cancer or whether a mediastinal lymph node dissection increases morbidity and mortality. METHODS: Prospectively co ...
Full textLink to itemCite
Journal ArticleAnn Surg Oncol · March 2006
BACKGROUND: The incidence of carcinoma of the gastroesophageal junction (GEJ) is rapidly increasing, and the prognosis remains poor. We examined outcomes in patients who received neoadjuvant chemoradiation for GEJ tumors to identify factors that predict di ...
Full textLink to itemCite
Journal ArticleCancer Invest · February 2006
Since the introduction of the pneumonectomy as a technically feasible strategy for the treatment of lung cancer, surgical resection has played a pivotal role in the management of early stage non-small cell lung carcinoma (NSCLC). In the last two decades, s ...
Full textLink to itemCite
Journal ArticleNature · January 19, 2006
The development of an oncogenic state is a complex process involving the accumulation of multiple independent mutations that lead to deregulation of cell signalling pathways central to the control of cell growth and cell fate. The ability to define cancer ...
Full textLink to itemCite
OtherAnn Thorac Surg · December 2005
BACKGROUND: Extrapleural pneumonectomy for malignant pleural mesothelioma (MPM) is a high-risk procedure, and patients require careful preoperative staging to exclude advanced disease. Computed tomography, magnetic resonance imaging, and positron emission ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2005
BACKGROUND: Malignant central airway obstruction is difficult to manage and is associated with poor outcome. We sought to identify the short (< 30 days) and intermediate (> 30 days) benefits and risks of tracheobronchial stents in patients with malignant a ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · August 2005
BACKGROUND: The safety of bronchoplastic procedures after induction chemoradiotherapy is uncertain. This study examines short- and long-term outcomes after bronchoplastic procedures with and without induction therapy. METHODS: Between January 1997 and Sept ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · June 2005
7020 Background: Gene microarray analysis can identify signatures that reflect unique aspects of individual tumors and provide precise prognostic information. Previously, we identified gene expression signatures reflecting the deregulation of oncogenic sig ...
Link to itemCite
Journal ArticleLung Cancer · May 2005
PURPOSE: A major problem with the staging system for non-small cell lung cancer (NSCLC) is clinical underestimation of the extent of disease. Many patients with clinical stage 1 disease do not retain that designation following surgical resection. Herein, w ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · March 15, 2005
PURPOSE: To assess the relationship between molecular markers associated with chemotherapy resistance and survival in esophageal cancer patients treated with trimodality therapy. EXPERIMENTAL DESIGN: The original pretreatment formalin-fixed, paraffin-embed ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · 2005
Surgery as the sole therapy for locally advanced non-small cell lung cancer (NSCLC) is usually not curative. Adjuvant chemotherapy has been evaluated by several randomized Phase III trials and found to confer a survival benefit over surgery alone for stage ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2004
BACKGROUND: Esophagogastrectomy (EG) is a formidable operation with significant morbidity and mortality rates. Risk factor analyses have been performed, but few studies have produced strategies that have improved operative results. This study was performed ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · May 2004
BACKGROUND: The National Emphysema Treatment Trial, a randomized trial comparing lung volume reduction surgery with medical therapy for severe emphysema, included randomized and nonrandomized comparisons of the median sternotomy and video-assisted thoracos ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · May 2004
BACKGROUND: To evaluate the safety and effectiveness of a new biodegradable polymeric sealant to close intraoperative air leaks after pulmonary resection. METHODS: In a multicenter prospective randomized trial, 161 patients with a median age of 67 years ol ...
Full textLink to itemCite
OtherJ Thorac Cardiovasc Surg · March 2004
OBJECTIVE: The purpose of this study was to identify risk factors associated with the onset of atrial fibrillation after thoracic surgery to allow more targeted interventions in patients with the highest risk. METHODS: A comprehensive prospective database ...
Full textLink to itemCite
OtherJ Thorac Cardiovasc Surg · February 2004
BACKGROUND: Constitutive activation of the phosphoinositide 3-kinase/protein kinase B survival signal transduction pathway influences the intrinsic chemoresistance of cancer cells. This study evaluates the effect of LY294002, a pharmacologic inhibitor of p ...
Full textLink to itemCite
Journal ArticleOrthopedics · January 2004
Complex regional pain syndrome, vasospastic disorders, and hyperhidrosis are chronic and debilitating upper extremity problems. Twenty-nine consecutive patients treated with thoracoscopic sympathectomy are presented. Diagnoses included complex regional pai ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · December 2003
OBJECTIVES: The American College of Surgeons Oncology Group undertook a trial to ascertain whether positron emission tomography with 18F-fluorodeoxyglucose could detect lesions that would preclude pulmonary resection in a group of patients with documented ...
Full textLink to itemCite
OtherBr J Anaesth · November 2003
BACKGROUND: Aortic atheromatous disease is known to be associated with an increased risk of perioperative stroke in the setting of cardiac surgery. In this study, we sought to determine the relationship between cerebral microemboli and aortic atheroma burd ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · November 2003
OBJECTIVE: To determine whether early identification of physiologic variances associated with interstage death would reduce mortality, we developed a home surveillance program. METHODS: Patients discharged before initiation of home surveillance (group A, n ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · July 2003
BACKGROUND: The long-term survival of patients with stage III non-small cell lung cancer treated with a combination of chemotherapy and radiation is 10% to 20%. Survival could potentially be increased and toxicity limited if one could identify patients mos ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · May 2003
OBJECTIVE: Debate continues as to whether transhiatal esophagectomy results in lower morbidity and mortality than transthoracic esophagectomy. Most data addressing this issue are derived from single-institution studies. To investigate this question from a ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · February 2003
Featured Publication
PURPOSE: Underestimation of disease severity is a major problem confronting the successful clinical management of non-small cell lung cancer. Recent advances in molecular biological substaging may provide an opportunity to identify those patients with the ...
Link to itemCite
Journal ArticleAnn Thorac Surg · January 2003
Featured Publication
BACKGROUND: The Department of Veterans Affairs National Surgical Quality Improvement Program is a unique resource to prospectively analyze surgical outcomes from a cross-section of surgical services nationally. We used this database to assess risk factors ...
Full textLink to itemCite
OtherJ Thorac Cardiovasc Surg · January 2003
OBJECTIVES: The objectives of the study were to test the hypothesis that hyperbaric levels of oxygen enhance the sensitivity of a sarcoma cell line to doxorubicin (Adriamycin) both in vitro and in vivo in a rat model of pulmonary metastases and to test the ...
Full textLink to itemCite
Journal ArticleChest Surg Clin N Am · August 2002
Featured Publication
Persistent air leaks prolong chest tube duration and hospital stay after lung surgery. Air leaks also may lead to life-threatening empyemas. Preventing postoperative air leaks and BPFs is the best treatment for air-leak complications. Meticulous closure of ...
Full textLink to itemCite
OtherAnesth Analg · July 2002
UNLABELLED: Renal dysfunction is common after coronary artery bypass graft (CABG) surgery. We have previously shown that CABG procedures complicated by stroke have a threefold greater peak serum creatinine level relative to uncomplicated surgery. However, ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · July 2002
Featured Publication
BACKGROUND: Positron emission tomography (PET) has been demonstrated to improve staging in patients with thoracic malignancies. This study evaluates the ability of a new imaging technique to improve the spatial resolution and accuracy of PET. METHODS: Pati ...
Full textLink to itemCite
Journal ArticleSurg Clin North Am · June 2002
Featured Publication
In both esophageal and NSCLC, the TNM stage at diagnosis remains the most important determinant of survival. Significant research to investigate the biology of NSCLC and esophageal carcinoma is ongoing, and the roles of proto-oncogenes, tumor suppressor ge ...
Full textLink to itemCite
OtherAnesth Analg · January 2002
UNLABELLED: Neurocognitive dysfunction is a common complication after cardiac surgery. We evaluated in this prospective study the effect of rewarming rate on neurocognitive outcome after hypothermic cardiopulmonary bypass (CPB). After IRB approval and info ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg · January 2002
Melanoma is the most deadly of skin cancers, and metastatic disease most commonly first appears in the lungs. Because most patients with early metastatic pulmonary disease are asymptomatic, routine screening with chest radiographs is the most cost-effectiv ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · October 2001
Featured Publication
BACKGROUND: The use of molecular markers in staging non-small cell lung cancer (NSCLC) has been supported in retrospective prognostic models but has not been evaluated in predicting sites of metastases. METHODS: Pathologic specimens were collected from 202 ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 2001
Featured Publication
BACKGROUND: This study was designed to determine the prognostic value of immunohistochemical tumor marker expression in a population of patients with node-negative esophageal cancer treated with complete resection alone. METHODS: Resection specimens were c ...
Full textLink to itemCite
Journal ArticleAnticancer Research · June 11, 2001
Background: CA 125 and CEA are valuable serum tumor markers that can be used to monitor response to therapy in patients with various solid tumors. Systemic studies of CA 125 and CEA have not been evaluated in lung cancer. In this study, we report the serum ...
Cite
Journal ArticleJ Clin Oncol · March 15, 2001
PURPOSE: HER-2 is overexpressed in 20% to 30% of human breast cancer and is associated with poor outcome. Studies suggest an association between HER-2 overexpression and resistance to alkylating agents. To further evaluate this relationship, we assessed th ...
Full textLink to itemCite
Journal ArticleClin Cancer Res · March 2001
Featured Publication
The purpose of this study was to define the prognostic value of a group of molecular tumor markers in a well-staged population of patients treated with trimodality therapy for esophageal cancer. The original pretreatment paraffin-embedded endoscopic esopha ...
Link to itemCite
Journal ArticleLung Cancer · 2001
Featured Publication
PURPOSE: To correlate FDG activity on PET with the expression of glucose transporter proteins Glut-1 and Glut-3 in patients with early stage non-small cell lung cancer (NSCLC). METHODS: Over a 5 year period, all patients with a PET scan and clinical stage ...
Full textLink to itemCite
Journal ArticleCancer Detect Prev · 2001
Our purpose was to determine whether peripheral blood biomarkers MUC1 and CK19 could be used to complement imaging studies in differentiating benign from malignant indeterminate pulmonary nodules or masses detected on computed tomography CT. One hundred an ...
Link to itemCite
Journal ArticleJ Natl Cancer Inst · November 15, 2000
BACKGROUND: The adenomatous polyposis coli (APC) locus on chromosome 5q21-22 shows frequent loss of heterozygosity (LOH) in esophageal carcinomas. However, the prevalence of truncating mutations in the APC gene in esophageal carcinomas is low. Because hype ...
Full textLink to itemCite
Journal ArticleChest Surg Clin N Am · November 2000
In summary, noninvasive clinical staging techniques aid in stratifying patients into similar prognostic and therapeutic categories. Every patient with presumed non-small cell lung cancer should undergo a thorough history and physical examination, basic rou ...
Link to itemCite
Journal ArticleChest Surg Clin N Am · August 2000
Several mechanisms of resistance to chemotherapy have been identified among the agents that are commonly used in the systemic treatment of patients with esophageal cancer: paclitaxel, platinum, and 5-FU. A recent study from our laboratory evaluated the ini ...
Link to itemCite
Journal ArticleChest · June 2000
OBJECTIVE: The purpose of this study was to determine the relationship between tumor size and survival in patients with stage IA non-small cell lung cancer (non-small cell lung cancer; ie, lesions < 3 cm). METHOD: Five hundred ten patients with pathologic ...
Full textLink to itemCite
Journal ArticleSemin Surg Oncol · March 2000
Clinical staging of lung cancer helps to determine the extent of disease and stratify patients into similar therapeutic and prognostic categories. A primary goal of clinical staging is to separate patients with potentially resectable disease from those tha ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · March 2000
BACKGROUND: This study is designed to assess molecular biologic substaging according to gender and histology in patients with stage I non-small cell lung cancer (NSCLC). METHODS: Pathologic specimens were collected from 408 consecutive patients after compl ...
Full textLink to itemCite
Journal ArticleChest · December 1999
The National Emphysema Treatment Trial is a multicenter, randomized clinical trial of medical therapy vs medical therapy plus lung volume reduction surgery (LVRS) for the treatment of patients with severe bilateral emphysema. LVRS will be accomplished by b ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · November 1999
BACKGROUND: Cardiac operations frequently are complicated by postoperative cognitive decline. Less common and less studied is postoperative cognitive decline after noncardiac surgery, so we determined its incidence, severity, and possible predictors. METHO ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 1999
OBJECTIVE: The standard treatment of patients with stage I non-small cell lung cancer is resection of the primary tumor; however, the recurrence rate is 28% to 45%. This study evaluates a panel of molecular markers in a large population of patients with st ...
Full textLink to itemCite
Journal ArticleJ Clin Oncol · July 1998
PURPOSE: To retrospectively construct a comprehensive multivariate model of cancer recurrence and to design a molecular pathologic substaging system in stage I non-small-cell lung cancer (NSCLC). METHODS: All patients with stage I NSCLC resected at Brigham ...
Full textLink to itemCite
Journal ArticleChest · September 1996
STUDY OBJECTIVE: The objective of the study was to investigate the impact of video-assisted thoracic surgery (VATS) on age-related morbidity and mortality for thoracic surgical procedures. DESIGN: Prospective data were collected on 896 consecutive VATS pro ...
Full textLink to itemCite
Journal ArticleAnn Surg · September 1996
OBJECTIVE: The authors examine the feasibility and efficacy of trimodality therapy in the treatment of malignant pleural mesothelioma and identify prognostic factors. BACKGROUND: Mesothelioma is a rare, uniformly fatal disease that has increased in inciden ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · September 1996
BACKGROUND: This study in humans assessed changes in left ventricular function early and late after correction of mitral regurgitation (MR) (n = 9) or aortic stenosis (AS) (n = 10). METHODS: Ventricular function was measured with radionuclide and micromano ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · May 1996
BACKGROUND: Although complete surgical resection remains the primary treatment for localized stage I non-small cell lung cancer, the cancer recurrence rate is 25% to 40%. If one could identify, a subset of patients using molecular factors that contribute t ...
Full textLink to itemCite
Journal ArticleCancer · September 1, 1995
BACKGROUND: Nonsmall cell lung cancer (NSCLC) has become the leading cause of cancer-related deaths in women and men in the United States, with more than 157,000 estimated deaths in 1995. Surgical resection remains the mainstay of therapy in Stage I and II ...
Full textLink to itemCite
Journal ArticleJ Am Coll Surg · August 1995
BACKGROUND: The application of video-endoscopy to general thoracic surgery is radically changing the approach to many benign and malignant diseases of the chest. Since July 1991, we have performed 794 purely thoracoscopic and 101 video-assisted thoracic su ...
Link to itemCite
Journal ArticleClin Cancer Res · June 1995
Historical information and pathological material from 150 consecutive patients with localized adenocarcinoma of the lung was collected to evaluate oncogene expression of erbB-2 and p53, and erbB-2 gene amplification. Pathological material after resection w ...
Link to itemCite
Journal ArticleJ Clin Oncol · May 1995
PURPOSE: Although standard treatment of stage I non-small-cell lung cancer (NSCLC) consists of surgical resection alone, approximately 50% of clinical stage I and 30% to 40% of pathologic stage I patients have disease recurrence and die following curative ...
Full textLink to itemCite
Journal ArticleCancer Res · January 1, 1995
In order to construct a multivariate model for predicting early recurrence and cancer death for patients with stage I non-small cell lung cancer, 271 consecutive patients (mean age, 63 +/- 8 years) who were diagnosed, treated, and followed at one instituti ...
Link to itemCite
Journal ArticleSemin Radiat Oncol · July 1994
Staging technology and the 1983 international staging system for esophageal cancer have changed. The 1988 system is based on depth of wall penetration and regional lymph node involvement; it abandons the previous criteria of tumor length and degree of obst ...
Full textLink to itemCite
Journal ArticleAm Heart J · August 1992
To compare left ventricular responses to stress during exercise-induced myocardial ischemia and after myocardial revascularization, 35 patients (mean age 55 +/- 7 years, class III angina) with three-vessel coronary artery disease underwent a rest and exerc ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · July 1992
From 1970 until 1990, 8,958 cases of primary carcinoma of the lung were diagnosed at the Duke University Medical Center. During the same period, 126 patients (mean age, 53 +/- 13 years) were diagnosed with bronchial carcinoid. The overall survival was 78% ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 1992
From 1970 to 1990, 7564 patients with melanoma were seen at Duke University Cancer Center. Complete follow-up data were available in all patients. The estimated probability of a pulmonary metastasis developing 5, 10, or 20 years after initial diagnosis was ...
Link to itemCite
Journal ArticleAm J Cardiol · August 1, 1990
To evaluate early and late hemodynamics after aortic valvuloplasty, 17 patients underwent first-pass radionuclide angiocardiography with simultaneous high-fidelity micromanometer pressure before, 10 minutes after and 6 months after aortic valvuloplasty. Pr ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · June 1990
Recent studies have suggested that excision of the mitral valve apparatus during mitral valve replacement impairs left ventricular performance. However, functional measurements in humans have been difficult to obtain in a load-independent fashion. To inves ...
Full textLink to itemCite
Journal ArticleAm J Cardiol · May 15, 1990
To evaluate the acute changes in left ventricular (LV) performance before and immediately after percutaneous aortic valvuloplasty, 25 patients underwent first-pass radionuclide angiocardiography for construction of pressure-volume loops. Simultaneously, hi ...
Full textLink to itemCite
Journal ArticleJ Thorac Cardiovasc Surg · April 1990
The purpose of this investigation was to examine changes in cardiac function after aortic valve replacement in patients with chronic aortic stenosis. Eleven consecutive patients with severe aortic stenosis were studied by radionuclide angiocardiography bef ...
Link to itemCite
Journal ArticleBr J Anaesth · March 1990
We have compared short axis images of the left ventricle (LV) obtained with transoesophageal echocardiography (TOE) to assess LV size and function with those obtained by radionuclide angiography (RNA). Simultaneous TOE and RNA images were attempted in 14 p ...
Full textLink to itemCite
Journal ArticleAm Heart J · January 1990
To evaluate the serial changes in right and left ventricular performance after percutaneous aortic balloon valvuloplasty, 15 patients, mean age 75 +/- 18 years, and in New York Heart Association (NYHA) class III, were studied with first-pass radionuclide a ...
Full textLink to itemCite
Journal ArticleCirculation · November 1989
To evaluate intraoperative changes in myocardial performance during valvular operations, ventricular functional measurements were obtained in 16 patients before and after elective cardiac valvular replacement. Six patients had mitral regurgitation, four ha ...
Link to itemCite
Journal ArticleAnn Surg · March 1989
To evaluate the effect of aortic occlusion and limb reperfusion on global and regional function of the right and left ventricle during infrarenal abdominal aortic aneurysm repair, 23 patients underwent five intraoperative first-pass radionuclide angiocardi ...
Full textLink to itemCite
Journal ArticleAm Heart J · February 1989
The relationship between dynamic changes in aortic valve gradient and left ventricular ejection performance in the early period after successful percutaneous aortic valvuloplasty has not been described in detail. Accordingly 20 adult patients with severe s ...
Full textLink to itemCite
Journal ArticleAnn Thorac Surg · November 1988
From 1970 to 1986, survival of 205 patients with alveolar cell carcinoma was retrospectively studied. Analysis examined the predictive value of presenting symptoms and diagnostic screening results for pathological Stage III or IV disease (advanced) and sur ...
Full textLink to itemCite
Journal ArticleCancer · August 15, 1988
Cutaneous malignant melanomas of the head and neck are prognostically engimatic. In addition to known prognostic determinants of stage and lesion microstage, lesion location also appears to have prognostic importance. The authors have reviewed a series of ...
Full textLink to itemCite
Journal ArticleCancer · March 15, 1985
Frequently the primary lesion of high-risk cutaneous melanoma (level III, greater than or equal to 1.5mm; greater than or equal to 1.0 mm with ulceration) is in an ambiguous lymphatic drainage site on the trunk, pelvic and shoulder girdles, and head and ne ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg
The peer-reviewed literature is often referenced to generalize outcomes for lung cancer surgeries performed within the Veterans Health Administration (VHA) and include assessments following resection of early stage non-small-cell lung cancer (NSCLC). We so ...
Full textLink to itemCite
Journal ArticleSemin Thorac Cardiovasc Surg
The objective of this study was to evaluate the impact of a video-assisted thoracoscopic (VATS) approach on outcomes in patients who underwent sleeve lobectomy for non-small-cell lung cancer (NSCLC). Outcomes of patients with cT1-T3, N0-N2, M0 NSCLC who un ...
Full textLink to itemCite